COMPOSITIONS AND METHODS FOR EX VIVO EXPANSION OF HUMAN HEMATOPOIETIC STEM/PROGENITOR CELLS
Described herein are methods of genetically modifying a quantity of expanded hematopoietic cells, comprising providing a quantity of hematopoietic cells; culturing the quantity of hematopoietic cells in the presence of at least one histone deacetylase inhibitor (HDACi) and at least one growth factor...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
17.02.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Described herein are methods of genetically modifying a quantity of expanded hematopoietic cells, comprising providing a quantity of hematopoietic cells; culturing the quantity of hematopoietic cells in the presence of at least one histone deacetylase inhibitor (HDACi) and at least one growth factor to expand the hematopoietic cells; and contacting the expanded hematopoietic cells with a nucleic acid sequence. The nucleic acid sequence modifies the quantity of expanded hematopoietic cells. Also described are compositions comprising the quantity of expanded hematopoietic cells produced. |
---|---|
Bibliography: | Application Number: EP20200190771 |